Actively Recruiting
Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients: an Epidemiological Survey
Led by University Hospital, Ghent · Updated on 2024-10-15
1000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand how transgender men use different methods for sexual intercourse after undergoing phalloplasty or metoidioplasty surgeries. It focuses on their satisfaction with various erectile aids and the satisfaction of their partners. These surgeries are gender-affirming procedures that create external genitalia, but achieving penetration often requires additional devices or aids. Since internal prostheses can have high complication rates, some patients use non-surgical aids, though their effectiveness and comfort are not well documented. Participants have undergone phalloplasty or metoidioplasty at least six months prior and are sexually active. This observational study collects data through a one-time questionnaire that covers the types of erectile aids used, satisfaction with these aids, and quality of sexual experiences. The study includes transgender or gender non-conforming individuals and their partners. The questionnaire explores recent sexual activity, sexual preferences, and satisfaction with sexual functioning and partner relationships. Participants will complete the questionnaire once, providing information on the aids they use and their sexual satisfaction. Researchers will analyze types of erectile aids, treatment satisfaction, epidemiology, and quality of sexual experience. This study helps provide valuable insights for healthcare providers and transgender men seeking alternatives to implanted erectile devices, improving advice and support after gender-affirming surgery.
CONDITIONS
Brief Title
Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient and partner age 18 years or older.
- Transgender or gender non-conforming individuals and their partners.
- Have undergone phalloplasty or metoidioplasty as genital gender affirming surgery.
- At least 6 months have passed since phalloplasty or metoidioplasty.
- Sexually active or have been sexually active with a partner since surgery.
- Voluntarily agree to anonymous use of data for scientific study.
You will not qualify if you...
- Patient under 18 years of age.
- Cisgender patients treated with phalloplasty or metoidioplasty.
- Less than 6 months since phalloplasty or metoidioplasty.
- Not sexually active since surgery.
- Patient or partner not interested in penetrative sexual intercourse.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - One time
Participants complete a detailed questionnaire about their sexual activity, use of erectile aids, and satisfaction with sexual function and partner relationships after genital gender-affirming surgery.
1 visit (in-person or remote)
Trial Site Locations
Total: 1 location
1
Department of Urology, University Hospital Ghent
Ghent, East-Flanders, Belgium, 9000
Actively Recruiting
Research Team
W
Wietse Claeys, MD
A
Anne-Françoise Spinoit, MD, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here